Nxp Semiconductors (NXPI)
$113.82
4.27 (3.90%)
NXPI Stock Quote Delayed 30 Minutes
Previous Close
$113.82
Market Cap
38.93B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
7.95M
Day's Range
113.30 - 118.85
52-Week Range
58.41 - 139.59
Dividend & Yield
0.21 (0.19%)
NXPI Stock Predictions, Articles, and Nxp Semiconductors News
NXP Semiconductors Earnings: NXPI Stock Dips 1% Lower on Q4 Results
NXP Semiconductors (NXPI) earnings for the tech company's fourth quarter of 2019 have NXPI stock falling in after-hours trading on Monday.
Stock Market Today: Cracks Show as Stocks Teeter
Free commissions rocked a number of retail-investor brokerage firms on Tuesday. Here's what else happened in the stock market today.
Nasdaq Today: Netflix Plunges on Earnings, Microsoft’s on Deck
Netflix, Microsoft, IBM, Qualcomm, eBay, AMD and Apple were some of the top movers and stocks to focus on in the Nasdaq today.
This Is What You Need to Know Before Investing in Nvidia Stock
Nvidia stock remains turbulent, as trade-war worries and a hearty crypto hangover continues to weigh on the company. However, NVDA is a long-term winner.
Nasdaq Today: Jobs Report Alters Rate-Cut Expectations, Moves Tech
Investors saw an almost 1% fall in the Nasdaq today after the jobs report. However, investors bid the index back toward break-even on Friday.
Inventory and Trade Victories Mean Smooth Sailing for Micron Stock
Micron stock got a nice bump from its latest announcement, and that just makes it stronger as trade tensions ease and inventory levels out.
Is Nvidia Stock a Buying Opportunity? Not So Fast
Nvidia stock has plenty of growth tailwinds, but valuation is a concern. If you're considering buying NVDA, wait for a pullback.
5 Top Stock Trades for Wednesday: AAPL, MCD, SHOP
Apple will report after the close, while MCD, PFE, SHOP and NXPI have all reported earnings. They're our top stock trades.
5 Semiconductor Stocks to Buy … If You Have a Strong Stomach
If you're willing to wait out some bumps in the road, these 5 semiconductor stocks look likely to deliver long-term gains for patient investors.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
